Evolus to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
Evolus, a performance beauty company, announced its participation in the 10th Annual SVB Leerink Global Healthcare Conference on February 24, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Evolus, a performance beauty company, announced its participation in the 10th Annual SVB Leerink Global Healthcare Conference on February 24, 2021. The event will feature a fireside chat and one-on-one meetings from 1:00 PM to 1:30 PM ET. An audio webcast of the chat will be available on Evolus' investor relations website, with replays accessible for 90 days. Evolus is known for its innovative products, including Jeuveau®, a neurotoxin dedicated to aesthetics, approved by the FDA in 2019.
Details
News Market Reaction – EOLS
The recorded move for EOLS in the trading session of this news was -10.58%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEWPORT BEACH, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of management will be participating in the 10th Annual SVB Leerink Global Healthcare Conference.
| Event: | 10th Annual SVB Leerink Global Healthcare Conference | ||
| Format: | Fireside Chat & 1x1 Meetings | ||
| Date: | Wednesday, February 24, 2021 | ||
| Time: | 1:00pm – 1:30pm ET | ||
| Location: | Evolus Live Fireside Chat |
An audio webcast of Evolus’ fireside chat will be available on the investor relations section of Evolus’ website at investors.evolus.com. Replays of the webcasts will be available for 90 days after the date of the presentation.
About Evolus, Inc.
Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. In 2019, the U.S. Food and Drug Administration approved Jeuveau® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure™ technology. Jeuveau® is powered by Evolus' unique technology platform and is designed to transform the aesthetic market by eliminating the friction points existing for customers today. Visit us at: www.evolus.com.
Jeuveau® is a registered trademark of Evolus, Inc.
Hi-Pure™ is a trademark of Daewoong Pharmaceutical Co, Ltd.
Evolus, Inc. Contacts:
Investor Contact:
Ashwin Agarwal, Evolus, Inc.
Vice President, Finance, Investor Relations & Treasury
Tel: +1-949-284-4559
Email: IR@Evolus.com
Media Contact:
Crystal Muilenburg, Evolus, Inc.
Vice President, Corporate Communications & Public Relations
Tel: +1-949-284-4506
Email: media@evolus.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.